"Receptors, KIR2DL1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A KIR receptor that has specificity for HLA-C ANTIGENS. It is an inhibitory receptor that contains D1 and D2 extracellular immunoglobulin-like domains and a long cytoplasmic tail. It is similar in structure and function to the KIR2DL2 RECEPTOR and the KIR2DL3 RECEPTORS.
- Receptors, KIR2DL1
- KIR2DL1 Receptors
- CD158a Antigen
- Antigen, CD158a
- Natural Killer-Associated Transcript 1
- Natural Killer Associated Transcript 1
- Antigens, CD158a
- CD158a Antigens
- Killer Cell Immunoglobulin-Like Receptor 2DL1
- Killer Cell Immunoglobulin Like Receptor 2DL1
Below are MeSH descriptors whose meaning is more general than "Receptors, KIR2DL1".
Below are MeSH descriptors whose meaning is more specific than "Receptors, KIR2DL1".
This graph shows the total number of publications written about "Receptors, KIR2DL1" by people in this website by year, and whether "Receptors, KIR2DL1" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, KIR2DL1" by people in Profiles.
Clinical impact of Fn-induced high expression of KIR2DL1 in CD8 T lymphocytes in oesophageal squamous cell carcinoma. Ann Med. 2022 Dec; 54(1):51-62.
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group. Clin Cancer Res. 2018 01 01; 24(1):189-196.
Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2015 Sep; 21(9):1589-96.